ERBB2 and triple-negative breast carcinoma: At least four major subtypes have been identified, including luminal A, luminal B, human epidermal growth factor receptor 2 (HER2), and triple-negative breast cancers (TNBC; lacking ER/PR/HER2) [3, 4].